| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3b356207f59953ba7525537f92bfc21f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1b74695f4c6259a8598b722c1ef6eefa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d81e519991facaa03fb36d4851f62313
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_eccbdca7d6da263f9b8fd6d7a750ad5f |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-28 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 |
| filingDate |
2019-09-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3cd6e0533d9df89a1954116d41a0a069
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0c2a6066359b16231c4b4265ea8a470f |
| publicationDate |
2021-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2021353682-A1 |
| titleOfInvention |
Pharmaceutical product for preventing or treating alzheimer's disease |
| abstract |
The present invention refers to a cell suspension comprising expanded autologous or allogeneic mesenchymal stromal cells derived from the bone marrow of a human subject, wherein said MSCs are suspended in the plasma fraction obtained from the peripheral blood from a patient or subject to be treated with the cell suspension, for use in the treatment or amelioration of a disease with cerebral impaired glucose metabolism, wherein said cell suspension is administered to the patient or subject via intrathecal (through an intrathecal administration), in particular by lumbar puncture. |
| priorityDate |
2018-09-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |